Managing data effectively can be challenging in any industry. But it’s especially difficult in pharmaceuticals, which faces ...

Ipsen has announced that it will be gaining exclusive global rights to Biomunex Pharmaceuticals’ pre-clinical T cell engager ...

The National Institute for Health and Care Excellence (NICE) has recommended Immunocore’s Kimmtrak (tebentafusp) as the first ...

GSK’s fully liquid presentation of its meningococcal vaccine Menveo has been approved by the European Commission (EC) to ...

A UK study has shown that a drug currently used to treat severe asthma could be re-purposed for use in emergency settings, ...

Gastric cancer is the fifth leading cause of cancer-related deaths globally and oesophageal cancer is the sixth ...

AstraZeneca (AZ) has announced positive high-level results from a late-stage study of its AKT inhibitor Truqap (capivasertib) ...

Sanofi has announced the opening of its new €558m-backed manufacturing facility in Singapore, which the company says ...

Policymakers, payers, providers, patients and pharma are each uniquely able to impact health equity – and together, achieve ...

Novartis’ Kisqali (ribociclib) has been approved by the European Commission (EC) to reduce the risk of disease recurrence in ...

GSK’s linerixibat has shown promising results in a late-stage trial of primary biliary cholangitis (PBC) patients with ...

The challenges facing the UK’s healthcare system and why putting the patient voice at the heart of our work is key ...